HOME >> BIOLOGY >> NEWS
Fetal and birth complications increase mental illness risks

Washington, DC -- New mental illness research offers bold insights into mental health risks associated with fetal and birth complications according to several papers published in the February 2000 issue of the American Journal of Psychiatry.

In a study at Columbia University and the New York State Psychiatric Institute, researchers learned the risk of developing major affective disorder increased in births exposed to famine in the second trimester and jumped significantly for subjects exposed in the third trimester.

["Further Evidence of Relation Between Prenatal Famine and Major Affect Disorder," by Alan S. Brown, et. al., p 190] APAfastFAX#6905

In a 19-year NIMH-supported longitudinal study using 693 men and women, researchers found hypoxic-ischemia-related fetal/neonatal complications could double the risk of developing a psychotic disorder. The study showed an elevated, graded, independent risk of schizophrenia and other nonaffected psychoses associated with this classification of antecedent hypoxic-ischemia-related fetal/neonatal complications.

["Hypoxic-Ischemia-Related Fetal/Neonatal Complications and Risk of Schizophrenia and Other Nonaffective Psychoses: A 19-Year Longitudinal Study," by Gwen L. Zornberg, et. al., p. 196] APAfastFAX#6904

In a third study by the Malmo University Hospital, Sweden, and the National Institute of Mental Health, Thomas F. McNeil and associates learned that trauma at the time of labor and delivery and especially prolonged labor appeared to be of importance for brain structure anomalies associated with schizophrenia.

["Relationship of Obstetric Complications and Differences in Size of Brain Structures in Monozygotic Twin Pairs Discordant for Schizophrenia," Thomas F. McNeil, et. al, p. 203] APAfastFAX#6903

Also in the February issue of the American Journal of Psychiatry:

Major Depressive Disorder Highly Recurrent

Researchers at the National Institute of Mental Health Collaborative Program
'"/>

Contact: Richard Ottinger
rottinger@psych.org
202-682-6119
American Psychiatric Association
27-Jan-2000


Page: 1 2

Related biology news :

1. Fetal lungs provide a signal initiating labor, UT Southwestern researchers find
2. Fetal death, miscarriage linked to genetic mutation
3. CDC MMWR: Fetal Alcohol Syndrome and Cutaneous Anthrax in a Lab Worker
4. Fetal research first in USA
5. Fetal and prepubertal growth both programme cholesterol metabolism in adulthood
6. Functional Arteries Grown From Cells Using Novel System That Simulates Fetal Environment
7. Study Suggests Maternal Stress And Stress Hormones May Influence Fetal Brain Development In Utero
8. Maternal Anxiety May Affect Fetal Development
9. Fetal Surgery For Spina Bifida Still Under Investigation At VUMC
10. Fetal Growth Rate Affects Risk Of Heart Disease
11. Fetal Lead Exposure May Reduce Immunity

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Fetal and birth complications increase mental illness risks

(Date:5/24/2013)... noise in one French Quarter neighborhood of New Orleans ... ordinances, Annette Hurley, PhD, Assistant Professor of Audiology at ... a third-year LSUHSC doctor of audiology student, recommend that ... health. Their case study is published online in the ... ., "An important part of an audiologist,s practice is ...
(Date:5/23/2013)... world,s most popular fruit, can be made both better-tasting ... varieties. , "Working with GM tomatoes that are ... a specific compound, allows us to pinpoint exactly how ... from the John Innes Centre. , The research could ... and shelf life characteristics because even higher levels of ...
(Date:5/23/2013)... suppresses lipid synthesis in the liver, UC Irvine endocrinologists ... liver diseases. , With this finding, Dr. Ellis ... in the field. Study results appear in the May ... , "The dogma in the steroid receptor field for ... the nucleus respond to steroid hormones by regulating genes ...
Breaking Biology News(10 mins):Please do try this at home 2The world's favorite fruit only better-tasting and longer-lasting 2UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2
(Date:5/24/2013)... (PRWEB) May 24, 2013 Vestiage, ... lifestyle company focused on science-based research and development, ... anti-aging cosmeceuticals and nutraceuticals, announced today that it ... States for the sale of Reluma Skin Illuminating ... packet and application by sending an email to ...
(Date:5/23/2013)...  BioScrip, Inc. (NASDAQ: BIOS ) today ... 2013 Global Healthcare Conference to be held June 3-6, ... Richard Smith , President and Chief ... Chief Financial Officer, will present on Monday, June 3, ... About BioScrip BioScrip, Inc. provides comprehensive infusion ...
(Date:5/23/2013)... Ind. , May 23, 2013  Rahal Letterman ... in human cord blood stem cell banking and therapeutics, ... of the No. 16 Acorn Stairlifts Indy car driven ... for the remainder of the IZOD IndyCar 2013 season. ... (RLL) will work to support awareness of umbilical cord ...
(Date:5/23/2013)... PARK, Calif. , May 23, 2013 ... oral treatment for pain has reached an important milestone, ... trial of VBY-036 - a selective cathepsin S inhibitor. ... VBY-036 is a double-blind, randomized, placebo-controlled study designed to ... doses of VBY-036 in healthy adults. "The ...
Breaking Biology Technology:Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3
Cached News: